Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-22T19:47:51.887Z Has data issue: false hasContentIssue false
  • English
  • Français

Metabolism of the soyabean isoflavone glycoside genistin in vitro by human gut bacteria and the effect of prebiotics

Published online by Cambridge University Press:  09 March 2007

Toni E. Steer ,
Ian T. Johnson ,
Jennifer M. Gee  and
Glenn R. Gibson
Toni E. Steer
Affiliation:
Food Microbial Sciences Unit, School of Food Biosciences, The University of Reading, Reading, Berks, UK
Ian T. Johnson
Affiliation:
Institute of Food Research, Norwich Research Park, Colney, Norwich, Norfolk, UK
Jennifer M. Gee
Affiliation:
Institute of Food Research, Norwich Research Park, Colney, Norwich, Norfolk, UK
Glenn R. Gibson*
Affiliation:
Food Microbial Sciences Unit, School of Food Biosciences, The University of Reading, Reading, Berks, UK
*
*Corresponding author: Dr Glenn R. Gibson, fax +44 118 935 7222, email [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The isoflavone genistein is found predominantly in soyabeans and is thought to possess various potent biological properties, including anti-carcinogenic effects. Studies have shown that genistein is extensively degraded by the human gut microflora, presumably with a loss of its anti-carcinogenic action. The aim of the present study was to investigate the potential of a prebiotic to divert bacterial metabolism away from genistein breakdown: this may be of benefit to the host. Faecal samples were obtained from healthy volunteers and fermented in the presence of a source of soyabean isoflavones (Novasoy™ (10g/l); ADM Neutraceuticals, Erith, Kent, UK). Bacterial genera of the human gut were enumerated using selective agars and genistein was quantified by HPLC. The experiment was repeated with the addition of glucose (10g/l) or fructo-oligosaccharide (10g/l; FOS) to the fermentation medium. The results showed most notably that counts of Bifidobacterium spp. and Lactobacillus spp. were significantly increased (P<0·05 and P<0·01 respectively) under steady-state conditions in the presence of FOS. Counts of Bacteroides spp. and Clostridium spp. were, however, both significantly reduced (P<0·05) during the fermentation. A decline in genistein concentration by about 52 and 56% over the 120h culture period was observed with the addition of glucose or FOS to the basal medium (P<0·01), compared with about 91% loss of genistein in the vessels containing Novasoy™ (ADM Neutraceuticals) only. Similar trends were obtained using a three-stage chemostat (gut model), in which once again the degradation of genistein was about 22% in vessel one, about 24% in vessel two and about 26% in vessel three in the presence of FOS, compared with a degradation of genistein of about 67% in vessel one, about 95% in vessel two and about 93% in vessel three in the gut model containing Novasoy™ (ADM Neutraceuticals) only. The present study has shown that the addition of excess substrate appeared to preserve genistein in vitro. In particular, the use of FOS not only augmented this effect, but also conferred an additional benefit in selectively increasing numbers of purportedly beneficial bacteria such as bifidobacteria and lactobacilli.

Keywords

GenisteinHuman gut microfloraMetabolismFructo-oligosaccharide
Type
Research Article
Information
British Journal of Nutrition , Volume 90 , Issue 3 , September 2003 , pp. 635 - 642
Copyright
Copyright © The Nutrition Society 2003

References

Adlercreutz, H (1995) Phytoestrogens: epidemiology and a possible role in cancer protection. Environ Health Perspect 103, 103–112.Google Scholar
Buddington, RK, Williams, CH, Chen, SC & Witherly, SA (1996) Dietary supplement of neosugar alters the fecal flora and decreases activities of some reductive enzymes in human subjects. Am J Clin Nutr 63, 709–716.CrossRefGoogle ScholarPubMed
Cassidy, A (1999) Dietary photoestrogens potential anti-cancer agents? Br Nutr Foundation Nutr Bull 24, 22–30.CrossRefGoogle Scholar
Chang, YC & Nair, MG (1995) Metabolism of diadzein and genistein by intestinal bacteria. J Nat Prod 58, 1892–1896.CrossRefGoogle ScholarPubMed
Day, AJ, Canada, FJ, Diaz, JC, et al. (2000) Dietary flavonoid and isoflavone glycosides are hydrolysed by the lactase site of lactase phlorizin hydrolase. FEBS Lett 468, 166–170.CrossRefGoogle ScholarPubMed
Day, AJ, DuPont, MS, Ridley, S, et al. (1998) Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver beta-glucosidase activity. FEBS Lett 425, 71–75.CrossRefGoogle Scholar
De Boever, P, Deplancke, B & Verstraete, W (2000) Fermentation by gut microbiota cultured in a simulator of the human intestinal microbial ecosystem is improved by supplementing a soygerm powder. J Nutr 130, 2599–2606.CrossRefGoogle Scholar
Friend, DR & Chang, GW (1984) A colon-specific drug-delivery system based on drug glycosides and the glycosidases of colonic bacteria. J Med Chem 27, 261–266.CrossRefGoogle ScholarPubMed
Gibson, GR, Beatty, ER, Wang, X & Cummings, JH (1995) Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 108, 975–982.CrossRefGoogle ScholarPubMed
Griffiths, LA & Smith, GE (1972) Metabolism of apigenin and related compounds in the rat. Biochem J 128, 901–911.CrossRefGoogle ScholarPubMed
Hawksworth, G, Drasar, BS & Hill, MJ (1971) Intestinal bacteria and the hydrolysis of glycosidic bonds. J Med Microbiol 4, 451–459.CrossRefGoogle ScholarPubMed
Hidaka, H, Eida, T, Takizawa, T, Tokunaga, T & Tashiro, Y (1986) Effects of fructooligosaccharides on intestinal flora and human health. Bifido Microflora 5, 37–50.CrossRefGoogle Scholar
Hur, HG, Lay, JO, Beger, RD, Freeman, JP & Rafii, F (2000) Isolation of human intestinal bacteria metabolizing the natural isoflavone glycosides daidzin and genistin. Arch Microbiol 174, 422–428.CrossRefGoogle ScholarPubMed
Kim, HD, Yu, KU, Bae, EA & Han, JM (1998) Metabolism of puerarin and daidzein by human intestinal bacteria and their relation to in vitro cytotoxicity. Biol Pharm Bull 21, 628–630.CrossRefGoogle ScholarPubMed
Mitsuoka, T, Hidaka, H & Eida, T (1987) Effect of fructooligo-saccharides on intestinal microflora. Nahrung 31, 426–436.CrossRefGoogle Scholar
Murphy, PA, Song, TT, Buseman, G & Barua, K (1997) Isoflavones in soy based infant formulas. J Agric Food Chem 45, 4638–4653.CrossRefGoogle Scholar
Rumney, CJ & Rowland, IR (1992) In vivo and in vitro models of the human colonic flora. Curr Rev Food Sci Nutr 31, 299–331.CrossRefGoogle ScholarPubMed
Schoefer, L, Mohan, R, Braune, A, Birringer, M & Blaut, M (2002) Anaerobic C-ring cleavage of genistein and daidzein by Eubacterium ramulus. FEMS Microbiol Lett 208, 197–202.CrossRefGoogle ScholarPubMed
Setchell, KDR (1998) Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr 68, 1333S–1345S.Google ScholarPubMed
Setchell, KDR, Brown, NM, Desai, P, et al. (2001) Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavones supplements. J Nutr 131, 1362S–1375S.CrossRefGoogle ScholarPubMed
Wang, HJ & Murphy, PA (1994) Isoflavone content of commercial soybean foods. J Agric Food Chem 42, 1666–1673.CrossRefGoogle Scholar
Williams, CH, Witherly, SA & Buddington, RK (1994) Influence of dietary neosugar on selected bacterial groups of the human faecal microbiota. Microb Ecol Health Dis 7, 91–97.Google Scholar
Xu, XM & Thomas, ML (1995) Estrogen receptor-mediated direct stimulation of colon cancer cell growth in vitro. Mol Cell Endocrinol 105, 197–201.Google Scholar